Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients
Andrea Chiricozzi(Università Cattolica del Sacro Cuore), Ketty Peris(Agostino Gemelli University Polyclinic), Niccolò Gori(Università Cattolica del Sacro Cuore), Laura Calabrese(University of Siena), Cristiano Caruso(Agostino Gemelli University Polyclinic), Giacomo Caldarola(Università Cattolica del Sacro Cuore), Flaminia Antonelli(Università Cattolica del Sacro Cuore), Clara De Simone(IRCCS San Camillo Hospital), Lucia Di Nardo(Università Cattolica del Sacro Cuore), Cristina Guerriero(Foundation Center)
Cited by 25
Related Papers
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
|Clinical Reviews in Allergy & Immunology|2018|738
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*
|British Journal of Dermatology|2020|590
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
|European Journal of Cancer|2016|579
Scanning the Immunopathogenesis of Psoriasis
|International Journal of Molecular Sciences|2018|317
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
|European Journal of Cancer|2009|316